E Fund Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
17,580
+406
| +2% | +$10.8K | 0.02% | 237 |
|
|
2025
Q1 | $415K | Sell |
17,174
-2,098
| -11% | -$50.7K | 0.02% | 245 |
|
|
2024
Q4 | $776K | Buy |
19,272
+2,992
| +18% | +$120K | 0.04% | 174 |
|
|
2024
Q3 | $1.03M | Sell |
16,280
-4,100
| -20% | -$260K | 0.05% | 141 |
|
|
2024
Q2 | $1.08M | Buy |
20,380
+14,342
| +238% | +$760K | 0.06% | 121 |
|
|
2024
Q1 | $495K | Sell |
6,038
-16,157
| -73% | -$1.32M | 0.03% | 159 |
|
|
2023
Q4 | $413K | Sell |
22,195
-6,582
| -23% | -$122K | 0.03% | 194 |
|
|
2023
Q3 | $319K | Buy |
28,777
+10,374
| +56% | +$115K | 0.02% | 201 |
|
|
2023
Q2 | $298K | Sell |
18,403
-12,273
| -40% | -$199K | 0.02% | 218 |
|
|
2023
Q1 | $511K | Buy |
+30,676
| New | +$511K | 0.04% | 126 |
|
|
2021
Q1 | $92K | Buy |
+14,481
| New | +$92K | 0.01% | 244 |
|